Pathogenicity and protective immunogenicity of cysteine proteinase-deficient mutants of Leishmania mexicana in non-murine models

Nancy Gore Saravia, Blanca Escorcia, Yaneth Osorio, Liliana Valderrama, Darren Brooks, Lourdes Arteaga, Graham Coombs, Jeremy Mottram, Bruno Travi

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

This study demonstrates that deletion of cysteine proteinase (CP) genes diminishes pathogenicity of Leishmania mexicana in non-murine experimental host models while preserving immunogenicity. Both cpb and cpa/cpb-deficient lines induced delayed disease onset, smaller lesions and lower parasite burden in hamsters. cpa/cpb-deficient L. mexicana grew more slowly as promastigotes and presented lower infectivity and growth in human mononuclear phagocytic host cells. Protection against homologous challenge comparable to that induced by infection with the virulent wild-type (WT) L. mexicana strain was achieved in the highly susceptible hamster model by immunization with 1000 cpb-deficient promastigotes. CP-deficient L. mexicana elicited significantly lower levels of Th2-associated cytokines IL-10 and TGF-β than the WT in the primary lesion of hamsters. These findings support the feasibility of using genetically attenuated live Leishmania to achieve protective immunity.

Original languageEnglish (US)
Pages (from-to)4247-4259
Number of pages13
JournalVaccine
Volume24
Issue number19
DOIs
StatePublished - May 8 2006
Externally publishedYes

Fingerprint

Leishmania mexicana
Cysteine Proteases
cysteine proteinases
Virulence
pathogenicity
hamsters
immune response
Cricetinae
promastigotes
mutants
lesions (animal)
human growth
Leishmania
Phagocytes
interleukin-10
Interleukin-10
Immunity
Immunization
immunization
Parasites

Keywords

  • Cysteine proteinases
  • Golden hamster
  • Leishmania
  • Live-attenuated vaccine

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Pathogenicity and protective immunogenicity of cysteine proteinase-deficient mutants of Leishmania mexicana in non-murine models. / Saravia, Nancy Gore; Escorcia, Blanca; Osorio, Yaneth; Valderrama, Liliana; Brooks, Darren; Arteaga, Lourdes; Coombs, Graham; Mottram, Jeremy; Travi, Bruno.

In: Vaccine, Vol. 24, No. 19, 08.05.2006, p. 4247-4259.

Research output: Contribution to journalArticle

Saravia, NG, Escorcia, B, Osorio, Y, Valderrama, L, Brooks, D, Arteaga, L, Coombs, G, Mottram, J & Travi, B 2006, 'Pathogenicity and protective immunogenicity of cysteine proteinase-deficient mutants of Leishmania mexicana in non-murine models', Vaccine, vol. 24, no. 19, pp. 4247-4259. https://doi.org/10.1016/j.vaccine.2005.05.045
Saravia, Nancy Gore ; Escorcia, Blanca ; Osorio, Yaneth ; Valderrama, Liliana ; Brooks, Darren ; Arteaga, Lourdes ; Coombs, Graham ; Mottram, Jeremy ; Travi, Bruno. / Pathogenicity and protective immunogenicity of cysteine proteinase-deficient mutants of Leishmania mexicana in non-murine models. In: Vaccine. 2006 ; Vol. 24, No. 19. pp. 4247-4259.
@article{acf4aa3cef614e91a16d42c347c8b51e,
title = "Pathogenicity and protective immunogenicity of cysteine proteinase-deficient mutants of Leishmania mexicana in non-murine models",
abstract = "This study demonstrates that deletion of cysteine proteinase (CP) genes diminishes pathogenicity of Leishmania mexicana in non-murine experimental host models while preserving immunogenicity. Both cpb and cpa/cpb-deficient lines induced delayed disease onset, smaller lesions and lower parasite burden in hamsters. cpa/cpb-deficient L. mexicana grew more slowly as promastigotes and presented lower infectivity and growth in human mononuclear phagocytic host cells. Protection against homologous challenge comparable to that induced by infection with the virulent wild-type (WT) L. mexicana strain was achieved in the highly susceptible hamster model by immunization with 1000 cpb-deficient promastigotes. CP-deficient L. mexicana elicited significantly lower levels of Th2-associated cytokines IL-10 and TGF-β than the WT in the primary lesion of hamsters. These findings support the feasibility of using genetically attenuated live Leishmania to achieve protective immunity.",
keywords = "Cysteine proteinases, Golden hamster, Leishmania, Live-attenuated vaccine",
author = "Saravia, {Nancy Gore} and Blanca Escorcia and Yaneth Osorio and Liliana Valderrama and Darren Brooks and Lourdes Arteaga and Graham Coombs and Jeremy Mottram and Bruno Travi",
year = "2006",
month = "5",
day = "8",
doi = "10.1016/j.vaccine.2005.05.045",
language = "English (US)",
volume = "24",
pages = "4247--4259",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "19",

}

TY - JOUR

T1 - Pathogenicity and protective immunogenicity of cysteine proteinase-deficient mutants of Leishmania mexicana in non-murine models

AU - Saravia, Nancy Gore

AU - Escorcia, Blanca

AU - Osorio, Yaneth

AU - Valderrama, Liliana

AU - Brooks, Darren

AU - Arteaga, Lourdes

AU - Coombs, Graham

AU - Mottram, Jeremy

AU - Travi, Bruno

PY - 2006/5/8

Y1 - 2006/5/8

N2 - This study demonstrates that deletion of cysteine proteinase (CP) genes diminishes pathogenicity of Leishmania mexicana in non-murine experimental host models while preserving immunogenicity. Both cpb and cpa/cpb-deficient lines induced delayed disease onset, smaller lesions and lower parasite burden in hamsters. cpa/cpb-deficient L. mexicana grew more slowly as promastigotes and presented lower infectivity and growth in human mononuclear phagocytic host cells. Protection against homologous challenge comparable to that induced by infection with the virulent wild-type (WT) L. mexicana strain was achieved in the highly susceptible hamster model by immunization with 1000 cpb-deficient promastigotes. CP-deficient L. mexicana elicited significantly lower levels of Th2-associated cytokines IL-10 and TGF-β than the WT in the primary lesion of hamsters. These findings support the feasibility of using genetically attenuated live Leishmania to achieve protective immunity.

AB - This study demonstrates that deletion of cysteine proteinase (CP) genes diminishes pathogenicity of Leishmania mexicana in non-murine experimental host models while preserving immunogenicity. Both cpb and cpa/cpb-deficient lines induced delayed disease onset, smaller lesions and lower parasite burden in hamsters. cpa/cpb-deficient L. mexicana grew more slowly as promastigotes and presented lower infectivity and growth in human mononuclear phagocytic host cells. Protection against homologous challenge comparable to that induced by infection with the virulent wild-type (WT) L. mexicana strain was achieved in the highly susceptible hamster model by immunization with 1000 cpb-deficient promastigotes. CP-deficient L. mexicana elicited significantly lower levels of Th2-associated cytokines IL-10 and TGF-β than the WT in the primary lesion of hamsters. These findings support the feasibility of using genetically attenuated live Leishmania to achieve protective immunity.

KW - Cysteine proteinases

KW - Golden hamster

KW - Leishmania

KW - Live-attenuated vaccine

UR - http://www.scopus.com/inward/record.url?scp=33646131385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646131385&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2005.05.045

DO - 10.1016/j.vaccine.2005.05.045

M3 - Article

C2 - 16216395

AN - SCOPUS:33646131385

VL - 24

SP - 4247

EP - 4259

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 19

ER -